HomeProductsInnovative ImplantInterventional ConsumablesSinus Drug-eluting Stent

Sinus Drug-eluting Stent

Description:
Qinovo's sinus drug-eluting stent is placedafter FESS surgery to helpkeeping the sinusesopen,delivering medication and mechanicalsupport to prevent tissue adhesion.
 
.Qinovo Sinus stent keep the sinuses open,prevent adhesion while releasing Mometa-sone Furoate(MF).
·Biodegradable stent 
·Patent compression and grip box making operation convenient.
.Over 5 sizes in 13models,physician canselect the most suitable model to meet patient need.

Share:

  • Detailed Description

Description

 Sinus implants are clinically proven to maintain patency and improve patient outcomes following endoscopic sinus surgery by targeting inflammation, the underlying cause of chronic rhinosinusitis.

  •  Sinus implants keep the sinuses open while releasing mometasone furoate
  •   Bio-absorbs over 30–45 after placement as the sinus cavity heals

.Qinovo Sinus stent keep the sinuses open,prevent adhesion while releasing Mometa-sone Furoate(MF).
·Containing of MometasoneFuroate,graduallyreleasing over 30 days.
·Biodegradable stent provides support for
more than 28 days.
·Patent compression and grip box making
operation convenient.
.Over 5 sizes in 13models,physician canselect the most suitable model to meet pa-tient need.

Product FAQ

WhatsApp

Leave a message!

Leave a message!